Format

Send to

Choose Destination
See comment in PubMed Commons below
Haematologica. 2014 Feb;99(2):e14-6. doi: 10.3324/haematol.2013.090142.

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.

Author information

1
appalumbo@yahoo.com.

KEYWORDS:

BLIMP1; IRF4; XBP1; bortezomib; multiple myeloma biomarker

PMID:
24497562
PMCID:
PMC3912976
DOI:
10.3324/haematol.2013.090142
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center